Register information Patent

DE file number : 60 2011 071 527.5 (Status: pending/in force, Query started: June 13, 2025)

Please note: This English version is a non-binding translation of the German register excerpt. Only the German version of the register excerpt is legally binding.

Master data
INIDCriterionFieldContent
Type of IP rightSARTPatent
StatusSTPending/in force
21DE file number DAKZ60 2011 071 527.5
96EP file numberEAKZ19 19 2508.0
97EP publication numberEPN3626257
54Designation/titleTIVERFAHREN UND ZUSAMMENSETZUNGEN ZUR ABGABE DER ARYLSULFATASE A IN DAS ZNS
51IPC main classICM
(ICMV)
A61K 38/47 (2006.01)
51IPC secondary class(es)ICS
(ICSV)
A61P 25/00 (2006.01), A61P 25/28 (2006.01), A61K 9/19 (2006.01), A61K 38/46 (2006.01)
22DE application dateDATJun 25, 2011
96EP application dateEATJun 25, 2011
43Date of first publicationOTMar 25, 2020
Date of publication of grantPETAug 4, 2021
71/73Applicant/ownerINHTakeda Pharmaceutical Company Limited, Osaka-shi, Osaka, JP
72InventorINSALAMAT-MILLER, Nazila, Arlington, MA Massachusetts 02474, US; TAYLOR, Katherine, Arlington, MA Massachusetts 02476, US; CAMPOLIETO, Paul, Charlottesville, VA Virginia 22903, US; SHAHROKH, Zahra, Weston, MA Massachusetts 02493, US; PAN, Jing, Boxborough, MA Massachusetts 01719, US; CHARNAS, Lawrence, Natick, MA Massachusetts 01760, US; WRIGHT, Teresa Leah, Lexington, MA Massachusetts 02142, US; CALIAS, Pericles, Melrose, MA Massachusetts 02176, US
74RepresentativeVTRMüller-Boré & Partner Patentanwälte PartG mbB, 80639 München, DE
Address for service Müller-Boré & Partner Patentanwälte PartG mbB, 80639 München, DE
33
31
32
Foreign priorityPRC
PRNA
PRDA
US
38786210 P
Sep 29, 2010
33
31
32
Foreign priorityPRC
PRNA
PRDA
US
36078610 P
Jul 1, 2010
33
31
32
Foreign priorityPRC
PRNA
PRDA
US
201161442115 P
Feb 11, 2011
33
31
32
Foreign priorityPRC
PRNA
PRDA
US
201161435710 P
Jan 24, 2011
33
31
32
Foreign priorityPRC
PRNA
PRDA
US
201161476210 P
Apr 15, 2011
33
31
32
Foreign priorityPRC
PRNA
PRDA
US
35885710 P
Jun 25, 2010
33
31
32
Foreign priorityPRC
PRNA
PRDA
US
201161495268 P
Jun 9, 2011
Due dateFT
FG
Jun 30, 2026
Annual fee for the 16th year Patent fees
Patent division in charge 44
97EP language of publicationELANGEN - Englisch
84Designated EP contracting statesEDSAL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Published EP/WO documentsEPWOPNOriginal document: EP000003626257A1
Searchable text: EP000003626257A1
Original document: EP000003626257B1
Searchable text: EP000003626257B1
43Date of first publicationEVTMar 25, 2020
Date of the first transfer into DPMAregisterEREGTMar 24, 2020
Date of the (most recent) update in DPMAregisterREGTJun 3, 2025
(Show all update days)(Hide all update days)
  • Jun 3, 2025
    • Due date: changed
    • Procedures: Procedure relating to EP application, EPO publication of mention of grant , 04.08.2021: new
    • Procedures: Procedure relating to EP application, EPO publication of mention of grant , 04.08.2021: deleted
  • Dec 24, 2024
    • Procedures: New applicant/owner details, New applicant/owner details, 19.11.2024: changed
  • Nov 20, 2024
    • Applicant/owner: changed
    • Procedures: New applicant/owner details, New applicant/owner details, 19.11.2024: new
  • May 28, 2024; Jun 3, 2023; Jul 8, 2022; Jun 23, 2022; May 26, 2022; Oct 30, 2021; Aug 19, 2021; Jul 16, 2021; Jul 15, 2021
    • Historical data not available for this/these date(s)
  • Mar 24, 2020
    • Date of the first transfer into DPMAregister
Procedural data
No.Kind of procedureLegal statusDate of legal/procedural statusPublication dateAlle Details anzeigen
1 Procedure relating to EP application EPO 1st publication Mar 25, 2020  Details anzeigen
2 Publications Publication of a mention regarding EP 1st publication by DPMA May 7, 2020 May 7, 2020 Details anzeigen
3 Procedure relating to EP application EPO publication of mention regarding patent grant (beginning of opposition period) Aug 4, 2021  Details anzeigen
4 Publications Publication by DPMA of mention regarding EP patent grant Aug 26, 2021 Aug 26, 2021 Details anzeigen
5 Procedure relating to EP application No opposition to patent grant filed, or opposition proceedings at EPO completed without decision May 6, 2022 Jul 28, 2022 Details anzeigen
6 New applicant/owner details New applicant/owner details Nov 19, 2024 Dec 24, 2024 Details anzeigen
View procedures Procedure relating to EP application (No.: 1)
INIDCriterionFieldContent Close details
Type of procedureVARTProcedure relating to EP application
Legal/procedural statusVSTEPO 1st publication
Date of legal/procedural statusVSTTMar 25, 2020
View procedures Publications (No.: 2)
INIDCriterionFieldContent Close details
Type of procedureVARTPublications
Legal/procedural statusVSTPublication of a mention regarding EP 1st publication by DPMA
Date of legal/procedural statusVSTTMay 7, 2020
Issue numberHN19
YearPJ2020
Publication dateVTMay 7, 2020
Type of publicationPARTBibliographic data
View procedures Procedure relating to EP application (No.: 3)
INIDCriterionFieldContent Close details
Type of procedureVARTProcedure relating to EP application
Legal/procedural statusVSTEPO publication of mention regarding patent grant (beginning of opposition period)
Date of legal/procedural statusVSTTAug 4, 2021
Date of update of the procedureREGTJun 3, 2025
View procedures Publications (No.: 4)
INIDCriterionFieldContent Close details
Type of procedureVARTPublications
Legal/procedural statusVSTPublication by DPMA of mention regarding EP patent grant
Date of legal/procedural statusVSTTAug 26, 2021
Issue numberHN34
YearPJ2021
Publication dateVTAug 26, 2021
Type of publicationPARTBibliographic data
PartHTPart 5
Date of update of the procedureREGTAug 19, 2021
View procedures Procedure relating to EP application (No.: 5)
INIDCriterionFieldContent Close details
Type of procedureVARTProcedure relating to EP application
Legal/procedural statusVSTNo opposition to patent grant filed, or opposition proceedings at EPO completed without decision
Date of legal/procedural statusVSTTMay 6, 2022
Issue numberHN30
YearPJ2022
Publication dateVTJul 28, 2022
Type of publicationPARTBibliographic data
PartHTPart 3
Date of update of the procedureREGTJul 8, 2022
View procedures New applicant/owner details (No.: 6)
INIDCriterionFieldContent Close details
Type of procedureVARTNew applicant/owner details
Legal/procedural statusVSTNew applicant/owner details
Date of legal/procedural statusVSTTNov 19, 2024
Issue numberHN52
YearPJ2024
Publication dateVTDec 24, 2024
Type of publicationPARTBibliographic data
PartHTPart 3
71/73Applicant/ownerINHTakeda Pharmaceutical Company Limited, Osaka-shi, Osaka, JP
71/73Previous applicant/ownerINHFShire Human Genetic Therapies, Inc., Lexington, MA, US
Date of update of the procedureREGTDec 24, 2024